Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia

Haemophilia

Volumn 15, Issue 6, 2009, Pages 1272-1280

  Jeng, M R ^a   O'Brien, M ^a   Wong, W ^a   Zoland, J ^a   Lea, J ^a   Tang, N ^a   Glader, B ^b  

^a Departments of Paediatrics   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catheters; Central venous access device; Haemophilia; Infections; Tissue plasminogen activator

Indexed keywords

ALTEPLASE;

ARTICLE; BLEEDING; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; HEMOPHILIA; HUMAN; INFANT; INFECTION RATE; INFECTIOUS COMPLICATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOSIS;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; EQUIPMENT CONTAMINATION; HEMOPHILIA A; HUMANS; INFANT; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 70449597449     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02063.x     Document Type: Article

References (39)

1. Naraine VS. Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique. Haemophilia 2002, 8:112-20.
2. Schultz WH. Prolonged use of an implantable central venous access system in a child with severe hemophilia. J Pediatr 1989, 114:100-1.
3. McWhirter WR, Gray L. Indwelling intravenous catheter in a young haemophiliac. Lancet 1988, 2:99-100.
4. Miser AW. Insertion of a central venous catheter for long-term venous access in a child with severe hemophilia and recurrent intracranial hemorrhage. Clin Pediatr (Phila) 1984, 23:589.
5. Joshi R. Use of a Hickman catheter for permanent venous access in a patient with severe haemophilia. Clin Lab Haematol 1982, 4:319-21.
6. Van Dijk K. Use of implantable venous access devices in children with severe hemophilia: benefits and burden. Haematologica 2004, 89:189-94.
7. Tarantino MD. Surveillance of infectious complications associated with central venous access devices in children with haemophilia. Haemophilia 2003, 9:588-92.
8. Collins PW. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br J Haematol 1997, 99:206-8.
9. Journeycake JM. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001, 98:1727-31.
10. Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999, 104:461-4.
11. Ljung R. Central venous catheters in children with haemophilia. Blood Rev 2004, 18:93-100.
12. Valentino LA. Central venous access devices in haemophilia. Haemophilia 2004, 10:134-46.
13. Blanchette VS. Central venous access catheters in children with haemophilia. Blood Coagul Fibrinolysis 1996, 7:S39-44.
14. Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 2003, 9:50-6.
15. Ljung R. Port-A-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr 1998, 87:1051-4.
16. Liesner RJ. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995, 91:203-7.
17. Perkins JL. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997, 19:339-44.
18. Santagostino E. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998, 102:1224-8.
19. Miller K. Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr 1998, 132:934-8.
20. McMahon C. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br J Haematol 2000, 110:461-8.
21. Morado M. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001, 7:551-6.
22. Bollard CM. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000, 6:66-70.
23. Neunert CE. Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience. Haemophilia 2008, 14:260-70.
24. Titapiwatanakun R. Central venous access devices for paediatric patients with haemophilia: a single-institution experience. Haemophilia 2009, 15:168-74.
25. Ljung R. Central venous lines in haemophilia. Haemophilia 2003, 9:88-92. discussion 93
26. Mancuso ME. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters. Br J Haematol 2008, 141:689-95.
27. Ragni MV, Journeycake JM, Brambilla DJ. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis. Haemophilia 2008, 14:30-8.
28. Dunn AL, Abshire TC. Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy. Pediatr Blood Cancer 2008, 50:627-9.
29. Daly L. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med 1992, 22:351-61.
30. Horan TC, Andrus M, Dudeck MA. CDC/NHSN Surveillance definitions of health care-associated infection and criteria for specific types of infections in the acute setting. Am J Infect Control 2008, 36:309-32.
31. Hacker MR. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy. J Pediatr Hematol Oncol 2007, 29:458-64.
32. Valentino LA, Kapoor M. Central venous access devices in patients with hemophilia. Expert Rev Med Devices 2005, 2:699-711.
33. Crary SE, Buchanan GR, Journeycake JM. Fatal central venous catheter-related infection in haemophilia. Haemophilia 2006, 12:183-6.
34. Hothi DK. Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters. Haemophilia 2001, 7:507-10.
35. Titapiwatanakun R, Pruthi R, Schmidt K, Slaby JA, Rodriguez V. Bacterial endocarditis and septic arthritis in a patient with severe hemophilia A: a case report. J Pediatr Hematol Oncol 2009, 31:344-5.
36. Sack K. Medicare won't pay for medical errors. NY Times 2008, October 1, p
37. Jeng MR. Central venous catheter complications in sickle cell disease. Am J Hematol 2002, 69:103-8.
38. Nicastri E. Catheter-related bloodstream infections in HIV-infected patients. Ann N Y Acad Sci 2001, 946:274-90.
39. Aitken ML, Tonelli MR. Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest 2000, 118:1598-602.